Multi-drug module ointment and preparation method thereof
A multi-module, drug-based technology, applied in the direction of ointment delivery, drug combination, drug delivery, etc., can solve problems such as wrong selection of ointment, complex causes of skin diseases, and difficult access to ointment treatment, etc., to achieve good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] The present embodiment provides a kind of multi-drug module ointment, and described ointment is made up of following components:
[0039] For the drug module 1 of pathogenic bacteria, the drug module 1 is made up of the following components: 3.8 parts by weight of erythromycin, 4.2 parts by weight of chloramphenicol, 1.9 parts by weight of tinidazole and 0.525 parts by weight of nano silver powder;
[0040] A drug module 2 directed at pathogenic fungi, the drug module 2 is composed of the following components: 4.2 parts by weight of amphotericin B, 3.8 parts by weight of clotrimazole, and 3.15 parts by weight of naftifine;
[0041] For the drug module 3 of the pathogenic virus, the drug module 3 is composed of the following components: 2.85 parts by weight of aciviro, 2.1 parts by weight of formic acid and 3.8 parts by weight of ribavirin;
[0042] A drug module 4 for desensitization, soothing and refreshing, the drug module 4 is composed of the following components: 0....
Embodiment 2
[0046] The present embodiment provides a kind of multi-drug module ointment, and described ointment is made up of following components:
[0047] For the drug module 1 of pathogenic bacteria, the drug module 1 is made up of the following components: 4.2 parts by weight of erythromycin, 3.8 parts by weight of chloramphenicol, 2.1 parts by weight of tinidazole and 0.475 parts by weight of nano silver powder;
[0048] A drug module 2 directed at pathogenic fungi, the drug module 2 is composed of the following components: 3.8 parts by weight of amphotericin B, 4.2 parts by weight of clotrimazole, and 2.85 parts by weight of naftifine;
[0049] Drug module 3 for pathogenic virus, said drug module 3 is made up of the following components: 3.15 parts by weight of aciviro, 1.9 parts by weight of formic acid and 4.2 parts by weight of ribavirin;
[0050] A drug module 4 for desensitization, soothing and refreshing, the drug module 4 is composed of the following components: 0.8 parts by ...
Embodiment 3
[0054] The present embodiment provides a kind of multi-drug module ointment, and described ointment is made up of following components:
[0055] For the drug module 1 of pathogenic bacteria, the drug module 1 is made up of the following components: 4 parts by weight of erythromycin, 4 parts by weight of chloramphenicol, 2 parts by weight of tinidazole and 0.5 parts by weight of nano silver powder;
[0056] A drug module 2 aimed at pathogenic fungi, the drug module 2 is composed of the following components: 4 parts by weight of amphotericin B, 4 parts by weight of clotrimazole, and 3 parts by weight of naftifine;
[0057] For the drug module 3 of the pathogenic virus, the drug module 3 is composed of the following components: 3 parts by weight of aciviro, 2 parts by weight of formic acid and 4 parts by weight of ribavirin;
[0058] A drug module 4 for desensitization, soothing and refreshing, the drug module 4 is composed of the following components: 0.84 parts by weight of dex...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
